MedPath

Measuring 5-ASA urinary excretion levels in healthy volunteers

Conditions
pilot studie gezonde vrijwilligers
urinary excretion 5-ASA
Registration Number
NL-OMON36986
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

Age>18 and <80 years and no significant co morbidities or co-medication

Exclusion Criteria

Pregnancy, significant co morbidities or co-medication, use of NSAIDs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcome is the reproducibility and variability in the urinary 5-ASA<br /><br>excretion, as measured with HPLC, in healthy volunteers, and to establish<br /><br>urinary 5-ASA cut-off levels for adherence. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcome is safety in terms of adverse events and rate of<br /><br>discontinuation due to adverse events of using 5-ASA. Daily morning urine<br /><br>samples will be collected and frozen at -20° before analysis. </p><br>
© Copyright 2025. All Rights Reserved by MedPath